Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Virtici, LLC

Website

Advertisement

Advertisement

464 12th Ave Ste 400
Seattle, WA 98122
https://virtici.com

Virtici, LLC is a Seattle-based company that focuses on providing innovative solutions in the field of technology. With a strong emphasis on ecosystem development and leadership, Virtici aims to deliver cutting-edge services and products to its clients.

Committed to staying at the forefront of the industry, Virtici, LLC strives to create a positive impact through its forward-thinking approach and dedication to excellence.

Generated from the website

Also at this address

Mark J Everard, MD - Recovery Center of King County

Surgery+Center+Of+Knox+County

Rhino Security Labs

Central Neighborhood Service Center

Own this business?
Claim it
See a problem?

You might also like

Testing laboratories

Oncoresponse, Inc

OncoResponse, Inc, based in Seattle, WA, is a biotechnology company focused on discovering novel cancer immunotherapies by leveraging elite immune responses. Their mission is to attack cancer by uncovering authentic human antibodies from exceptional responders to checkpoint inhibitor therapies, with a pipeline aimed at enhancing immune activity in the tumor microenvironment. Utilizing a clinically validated Technology Platform, OncoResponse aims to develop monoclonal antibodies that target immunosuppressive myeloid biology, ultimately aiming to transform cold tumors into hot ones. Through strategic partnerships and collaborations, the company is dedicated to advancing immuno-oncology and expanding the promise of immunotherapy.Generated from the website
Blood derivatives

Icosavax, Inc

Icosavax, Inc. is a clinical-stage biotechnology company based in Seattle, WA, dedicated to developing innovative vaccines using their unique virus-like particle (VLP) technology. Their VLPs are designed to mimic the structure of viruses, offering potential advantages such as a stronger immune response, broader coverage against related viral strains and mutations, longer durability, and easier combinability for multiple targets in one vaccine. With a focus on protecting vulnerable older adults from respiratory viruses, Icosavax aims to revolutionize the field of vaccines by creating a new era of immunization. Their cutting-edge approach has garnered attention, leading to an agreement to be acquired by AstraZeneca and positive interim Phase 2 results for their combination VLP vaccine candidate, IVX-A12, against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in older adults.Generated from the website
Medical research

Actx Inc

Actx Inc, based in Seattle, WA, offers genomic services and personalized user experiences through their website. Users can access and use the services by accepting the terms of service, which outline legal rights and obligations. The company provides a non-exclusive license to access and use their materials, including data, software, and information, while also emphasizing the importance of privacy and feedback. Actx reserves the right to modify terms and conditions, requiring users to review and accept any changes to continue using their services.Generated from the website
United States›Washington›Seattle›Virtici, LLC

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell